Guidance

Batch testing medicines if there's no Brexit deal

How batch testing medicines would be affected if the UK leaves the EU with no deal.

Documents

Details

If the UK leaves the EU in March 2019 without a deal, we’ll continue to:

  • accept batch testing of human medicines carried out in countries on a list from the Medicines and Healthcare products Regulatory Agency (MHRA)
  • require a UK, EU or EEA-based qualified person (QP) to certify batch testing
Published 23 August 2018
Last updated 14 September 2018 + show all updates
  1. Updated to inform that the notices may sometimes apply to businesses and citizens in the EEA.
  2. First published.